MedTech moulding trends to watch

Andrew Sargisson, regional medical director of the global Sumitomo (SHI) Demag team, shares his industry insight and predictions for the medical market, and how these latest trends are influencing investments in medical injection moulding facilities worldwide.

Andrew Sargisson, regional medical director, Global Sumitomo (SHI) Demag team.
Andrew Sargisson, regional medical director, Global Sumitomo (SHI) Demag team.

Medical technology (MedTech) is a multi-billion-dollar manufacturing sector. Thermoplastic and LSR moulding continues to be used extensively to manufacture a huge variety of everyday medical applications. The range is broad and can include implantable components, test tubes, petri dishes, PCR tubes, pipette tips and other labware, as well as medical monitoring devices, drug delivery components and surgical equipment.

The medical market, particularly diagnostics, was strongly influenced by the Coronavirus pandemic. As anticipated, there has been a natural levelling-off for pandemic-related consumables.

More recently, there is a stronger leaning in the medical market towards larger strategic and more complex projects, such as drug delivery devices and pen style injectors. This is predominantly due to the global growth in diabetes care, where demand for advanced glucose monitoring and insulin delivery devices is propelling innovation.


Read the full article in the MAG Online Library here